Oncoinvent ASA – New share capital registered

Oslo, Norway, 15 January 2026: Reference is made to the stock exchange announcement made by Oncoinvent ASA (the "Company") on 8 January 2026 regarding the resolution by the extraordinary general meeting of the Company to increase the share capital in connection with the issuance of 75 new shares to Abakus Invest AS for purposes of facilitating a reverse share split.

The share capital increase referred to above has today been registered with the Norwegian Register of Business Enterprises (Nw.: Foretaksregisteret). The new shares will be issued and registered in the CSD with ISIN NO 0013251173.

Following the registration, the Company's registered share capital is NOK 223,920,600, divided into 447,841,200 shares, each with a nominal value of NOK 0.50.

***